Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 3Neoplasms 3Breast Neoplasms 3Esophageal Neoplasms 2the Rate of Participation in Screening for PBC 1Venous Thromboembolism 1Uterine Cervical Diseases 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Radiation Injuries 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1Pneumonia 1Papillomavirus Infections 1Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Pancreatic Neoplasms 1Oncology Problem 1Neoplasm Metastasis 1Multiple Myeloma 1Mastocytosis 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Homosexuality 1Heart Diseases 1Head and Neck Neoplasms 1HIV Infections 1

Interventions

Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pulmonary Atelectasis × Mass Screening × Clear all
NCT04663958 2026-04-30

Predictive Value of Ariscat Index In The Development of Pulmonary Complication After Major Abdominal Cancer Surgery

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Completed
410 enrolled

Pulmonary Atelectasis, Neoplasms, Pneumonia, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡